22nd Jan to 28th Jan 2018
Hyatt Regency Miami
Cell and Gene Therapy World

The world’s only whole-ecosystem partnering event for the cell & gene therapy industry

With over 25 hours of networking built into the conference and over 350 organisations to meet, the opportunities for collaboration are limitless at the most senior partnering event in the cell and gene therapy sector.

David Venables, CEO Synpromics, will speak on the panel 'Comparing and contrasting different AAV serotypes and novel capsid modification-based approaches' at this event on 23rd January at 11:30.